US EditionCyted Health Expands US Presence with First Patients Enrolled in DETECT-ME Clinical Validation Study
- Cyted Health has enrolled its first patient in the DETECT-ME clinical validation study to assess its molecular assays for detecting Barrett's Esophagus and esophageal adenocarcinoma using an FDA-cleared device.
- The study, co-led by Dr. Nick Shaheen and Dr. Sachin Wani, will include participants from 18 US locations.
- Cyted Health aims to improve early detection of esophageal cancer, which has over 22,000 new cases in the US annually.
- Cyted Health's technology has been successful in the UK, and the company is expanding its presence in the US to enhance patient access to early diagnostic tools.
Insights by Ground AI
Does this summary seem wrong?
24 Articles
24 Articles
All
Left
Center
8
Right
3
hartfordcitynewstimes.com+23 Reposted by 23 other sources
Cyted Health Expands US Presence with First Patients Enrolled in DETECT-ME Clinical Validation Study
WILMINGTON, Del. and CAMBRIDGE, England, March 25, 2025 /PRNewswire/ -- Cyted Health, a leading gastrointestinal molecular diagnostics company, today announces the enrollment of the first patient in the DETECT-ME clinical validation study (NCT06803927). The study evaluates Cyted Health's advanced molecular…
·Hartford City, United States
Read Full ArticleCoverage Details
Total News Sources24
Leaning Left0Leaning Right3Center8Last UpdatedBias Distribution73% Center
Bias Distribution
- 73% of the sources are Center
73% Center
C 73%
R 27%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
